These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3468095)

  • 1. Anti-HTLV III testing of blood donors and recipients, Hawaii experience.
    Frohlich J
    Hawaii Med J; 1986 Nov; 45(11):391-2. PubMed ID: 3468095
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus development summaries. The impact of routine HTLV-III antibody testing of blood and plasma donors on public health. National Institutes of Health.
    Conn Med; 1986 Nov; 50(11):745-51. PubMed ID: 3466770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood transfusion and AIDS].
    Tokunaga E
    Nihon Rinsho; 1986 Oct; 44(10):2222-6. PubMed ID: 3469444
    [No Abstract]   [Full Text] [Related]  

  • 4. [HIV infection and blood donation services].
    Gathof B; Eberle J; Bäcker U; Deinhardt F; Gathof AG
    Internist (Berl); 1988 Feb; 29(2):124-30. PubMed ID: 3286563
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rational microanalysis technic in the detection of antibodies to HTLV-III, CMV and EBV with indirect immunofluorescence].
    Stöcker W; Geusendam G; Schmitz H; Mohr H; Berndt H
    Beitr Infusionther Klin Ernahr; 1986; 15():51-7. PubMed ID: 3019301
    [No Abstract]   [Full Text] [Related]  

  • 6. The community blood supply and patients' choice. The case for directed blood donations.
    Goldfinger D
    Hastings Cent Rep; 1987 Apr; 17(2):7-8. PubMed ID: 3473057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening of antiviral antibodies of human immunodeficiency in blood donors].
    Gelabert Blanes A
    Med Clin (Barc); 1987 May; 89(1):14-6. PubMed ID: 3475520
    [No Abstract]   [Full Text] [Related]  

  • 8. The community blood supply and patients' choice. Reconciling patients' wishes with the public good.
    Reiss RF; Pindyck J
    Hastings Cent Rep; 1987 Apr; 17(2):9-10. PubMed ID: 3473058
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of HTLV-III antibodies in blood donors at the German Red Cross].
    Kubanek B; Koerner K
    Dtsch Med Wochenschr; 1986 Mar; 111(13):516-7. PubMed ID: 3456890
    [No Abstract]   [Full Text] [Related]  

  • 10. Does antibody screening of donors increase the risk of transfusion-associated AIDS?
    Perkins JT; Miceli C; Janda WM
    N Engl J Med; 1985 Jul; 313(2):115-6. PubMed ID: 3858672
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 12. The community blood supply and patients' choice. The community: still the best source of blood.
    Mayer K
    Hastings Cent Rep; 1987 Apr; 17(2):5-7. PubMed ID: 3108195
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for HTLV-III antibodies--a government blunder?
    Bryan CS
    J S C Med Assoc; 1985 Apr; 81(4):242-4. PubMed ID: 2985870
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of routine HTLV-III antibody testing on public health.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(5):1-9. PubMed ID: 3537748
    [No Abstract]   [Full Text] [Related]  

  • 15. Counseling HIV-antibody positive blood donors.
    Van Devanter NL; Grisaffi JA; Steilen M; Scarola ME; Shipton RM; Tendler C; Pindyck J
    Am J Nurs; 1987 Aug; 87(8):1026-30. PubMed ID: 3474900
    [No Abstract]   [Full Text] [Related]  

  • 16. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of serum samples positive for HTLV-III antibodies.
    Petricciani JC; Seto B; Wells M; Quinnan G; McDougal JS; Bodner AJ
    N Engl J Med; 1985 Jul; 313(1):47-8. PubMed ID: 2582255
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Practical significance of the AIDS problem in blood donation services].
    Wernet P
    Beitr Infusionther Klin Ernahr; 1986; 15():39-50. PubMed ID: 3019300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.